Cmtm4 Deficiency Inhibits Helicobacter pylori-Induced Gastric Carcinogenesis
Yanfei Lang1,2, Xiurui Han1,2,3, Xin Liu1,2
1Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Pathology International
|May 28, 2025
Summary
CMTM4 deficiency inhibits Helicobacter pylori-induced gastric cancer (GC) by downregulating the IL-17 signaling pathway. This finding suggests CMTM4 as a potential target for GC prevention.
Area of Science:
- Gastroenterology
- Oncology
- Immunology
Background:
- Helicobacter pylori infection is a primary cause of gastric cancer (GC).
- Interleukin-17 (IL-17) mediated inflammation is critical in H. pylori infection and gastric carcinogenesis.
- The role of CMTM4, an IL-17 receptor subunit, in GC development is not well understood.
Purpose of the Study:
- To investigate the role of CMTM4 in H. pylori-induced gastric carcinogenesis.
- To elucidate the underlying molecular mechanisms involving IL-17 signaling.
Main Methods:
- Utilized Cmtm4 knockout (KO) mice to study H. pylori infection.
- Analyzed GC development, pseudopyloric metaplasia, and DNA damage.
- Investigated the IL-17 signaling pathway, including IL-17RC, NF-κB, and NOX1 expression.
Main Results:
- Cmtm4 deficiency significantly inhibited GC development and pseudopyloric metaplasia.
- Reduced DNA damage in the gastric mucosa of Cmtm4 KO mice.
- CMTM4 deletion downregulated the IL-17 signaling pathway, suppressing IL-17RC, NF-κB activation, and NOX1 levels.
Conclusions:
- CMTM4 plays a crucial role in promoting H. pylori-induced gastric carcinogenesis.
- CMTM4 deletion suppresses GC and precancerous lesions via the IL-17RC/NF-κB/NOX1 pathway.
- Targeting CMTM4 may offer a novel strategy for early GC prevention.
More Related Videos
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
561
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
561
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
609
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
609
Mucosal Barrier of the Stomach
850
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
850
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Gastritis-II: Pathophysiology
614
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
614
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
732
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
732


